Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care
Launched by UNIVERSITY OF LOUISVILLE · Mar 1, 2016
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
Computer-assisted cognitive-behavior therapy (CCBT) for depression in primary care will be evaluated in a trial with 320 patients randomly assigned to CCBT or treatment as usual (TAU). The study will disseminate a therapy method found to be effective in psychiatric settings into primary care - a setting where there have been significant problems in delivery of adequate, evidence-based treatment for depression. The study will include a high percentage of disadvantaged patients - a population that has been largely ignored in previous research in CCBT. There have been no previous studies of CC...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient Health Questionnaire score of 10 or above
- • 2. Age 18 or above
- Exclusion Criteria:
- • 1. Refusal to provide informed consent
- • 2. Inability to read English text on computer screen
- • 3. Significant suicidal thoughts, intent, plan, or behavior reported on Columbia Suicide Severity Rating Scale
- • 4. Severe or poorly controlled medical disorders that would interfere with participation in CCBT (e.g., liver failure, terminal cancer)
- • 5. Dementia or other organic brain disorders that would prevent participation in CCBT
- • 6. Diagnosis of any psychotic disorder or bipolar disorder.
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Jesse Wright, M.D., Ph.D.
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials